A Phase II Study of High-Dose Allovectin-7 in Patients With Advanced Metastatic Melanoma
Latest Information Update: 01 Feb 2012
At a glance
- Drugs Velimogene aliplasmid (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 01 Feb 2012 New trial record